Go backIncome
Assets
Total liabilities
Employees
Janssen Pharmaceutica
Janssen Research & Development
is not in process of liquidation on Apr 15, 2024
To view all financial indicators, unlock this company.
Income
Financial indicator20192018
Net sales
░░░░░░░░
0%
░░░░░░░░
0%
Turnover
14.6B EUR
22%
11.9B EUR
16%
Semi-finished goods and work-in-progress goods
░░░░░░░░
0%
░░░░░░░░
0%
Own construction capitalised
░░░░░░░░
0%
░░░░░░░░
0%
Other operating income
░░░░░░░░
0%
░░░░░░░░
0%
Cost of sales
░░░░░░░░
0%
░░░░░░░░
0%
Supplies and goods
░░░░░░░░
0%
░░░░░░░░
0%
Services and miscellaneous goods
░░░░░░░░
0%
░░░░░░░░
0%
Remuneration, social insurances, and other benefits
░░░░░░░░
0%
░░░░░░░░
0%
Depreciation and write-offs on formation expenses on formation expenses, intangible and tangible assets tangible assets
░░░░░░░░
0%
░░░░░░░░
0%
Write-downs on inventories, contracts in progress and orders in progress and trade receivables
░░░░░░░░
0%
░░░░░░░░
0%
Provisions for liabilities and charges
░░░░░░░░
0%
░░░░░░░░
0%
Other operating expenses
░░░░░░░░
0%
░░░░░░░░
0%
Non-recurring operating expenses
░░░░░░░░
0%
░░░░░░░░
0%
Operating profit
░░░░░░░░
0%
░░░░░░░░
0%
Financial income
░░░░░░░░
0%
░░░░░░░░
0%
Recurring financial income
░░░░░░░░
0%
░░░░░░░░
0%
Financial expenses
░░░░░░░░
0%
░░░░░░░░
0%
Recurring financial expenses
░░░░░░░░
0%
░░░░░░░░
0%
Profit before tax
░░░░░░░░
0%
░░░░░░░░
0%
Income tax
░░░░░░░░
0%
░░░░░░░░
0%
Net profit
1.65B EUR
43%
1.15B EUR
61%
Profit (Loss) to be allocated
░░░░░░░░
0%
░░░░░░░░
0%
Profit (Loss) for the year to be allocated
░░░░░░░░
0%
░░░░░░░░
0%
Profit (Loss) brought forward from the previous year
░░░░░░░░
0%
░░░░░░░░
0%
Assets
Financial indicator20192018
Total assets
15.7B EUR
12%
13.9B EUR
-1%
Non-current assets
░░░░░░░░
0%
░░░░░░░░
0%
Current assets
░░░░░░░░
0%
░░░░░░░░
0%
Total liabilities
Financial indicator20192018
Total liabilities
░░░░░░░░
0%
░░░░░░░░
0%
Equity
░░░░░░░░
0%
░░░░░░░░
0%
Provisions and deferred taxes
░░░░░░░░
0%
░░░░░░░░
0%
Debts
░░░░░░░░
0%
░░░░░░░░
0%
Employees
Financial indicator20192018
Employees
░░░░░░░░
0%
░░░░░░░░
0%
By type of employment contract
░░░░░░░░
0%
░░░░░░░░
0%
Contract for an indefinite period
░░░░░░░░
0%
░░░░░░░░
0%
By gender and education level
░░░░░░░░
0%
░░░░░░░░
0%
Men
░░░░░░░░
0%
░░░░░░░░
0%
Women
░░░░░░░░
0%
░░░░░░░░
0%
By professional category
░░░░░░░░
0%
░░░░░░░░
0%
Management staff
░░░░░░░░
0%
░░░░░░░░
0%
Employees
░░░░░░░░
0%
░░░░░░░░
0%
Workers
-
220
12%
Average number of workers (Full-time equivalents)
░░░░░░░░
0%
░░░░░░░░
0%
Full-time
░░░░░░░░
0%
░░░░░░░░
0%
Part-time
░░░░░░░░
0%
░░░░░░░░
0%
Number of hours actually worked
░░░░░░░░
0%
░░░░░░░░
0%
Full-time
░░░░░░░░
0%
░░░░░░░░
0%
Part-time
░░░░░░░░
0%
░░░░░░░░
0%
Your trusted source for business data
Socials
English, USA
English, USA